Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome.
about
Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespanDyslipidemia in women with polycystic ovary syndromeScientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.Evidence for gonadotrophin secretory and steroidogenic abnormalities in brothers of women with polycystic ovary syndromeParent-of-origin effects on glucose homeostasis in polycystic ovary syndrome.Intergenerational associations of chronic disease and polycystic ovary syndromeInsulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guidelineAssociations of birthweight and gestational age with reproductive and metabolic phenotypes in women with polycystic ovarian syndrome and their first-degree relatives.Prevalence of metabolic syndrome in the family members of women with polycystic ovary syndrome from North India.Metabolic phenotype in the brothers of women with polycystic ovary syndrome.The role of the polycystic ovary syndrome susceptibility locus D19S884 allele 8 in maternal glycemia and fetal sizeDevelopmental programming: insulin sensitizer treatment improves reproductive function in prenatal testosterone-treated female sheepThe American Diabetes Association's 57th annual advanced postgraduate course: diabetes risk, vitamin D, polycystic ovary syndrome, and obstructive sleep apnea.Prenatal androgen treatment alters body composition and glucose homeostasis in male ratsFamily association study between INSR gene polymorphisms and PCOS in Han Chinese.Evidence for increased cardiovascular events in the fathers but not mothers of women with polycystic ovary syndromeBirth weight and childhood growth in daughters of women with irregular menstrual cycles.Diagnosis and treatment of polycystic ovary syndrome (PCOS): an interview with Richard Legro.State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS).Paternal history of diabetes mellitus and hypertension affects the prevalence and phenotype of PCOS.Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohortsFamilial aggregation of circulating C-reactive protein in polycystic ovary syndromeContemporary medical therapy for polycystic ovary syndrome.Hyperandrogenism and hyperinsulinism in children of women with polycystic ovary syndrome: a controlled studyPerspectives in Polycystic Ovary Syndrome: From Hair to EternityTargets to treat metabolic syndrome in polycystic ovary syndromeRisk of cardiovascular events in mothers of women with polycystic ovary syndrome.Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose-effect association with prevalent cardiovascular diseaseThe role of genetic variation in the lamin a/c gene in the etiology of polycystic ovary syndrome.Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2.Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.High prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity.Variation in the perilipin gene (PLIN) affects glucose and lipid metabolism in non-Hispanic white women with and without polycystic ovary syndrome.Excess mortality in mothers of patients with polycystic ovary syndrome.The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis.Cardiometabolic Risk in PCOS: More than a Reproductive Disorder.Computational characterization and identification of human polycystic ovary syndrome genesHyperinsulinaemic androgen excess in adolescent girls
P2860
Q21245262-F702BCF1-048B-4586-B76C-9ECF2C62FB86Q27025695-1DD67883-C8DE-43B9-B7C8-6B3FCA7AE95FQ28390200-BD5173C1-66E8-4AA7-9554-5926C3FFA385Q30303066-376C0276-74C0-4C99-AB84-6B043801D53AQ30371644-EB18BE75-8502-4CC3-8744-A255237352CDQ31032859-764D84BC-BD84-4EE2-BE89-0F6F9285225AQ33569169-2C9E0DCD-A8FE-46DF-9CCB-D6CDD5C866D3Q33587845-8F8FB385-31F2-4FD8-8B68-699D2A46C154Q33736117-E9D9632C-0F78-4C14-A99F-F40040AD55E1Q33750469-AD319B6F-BAE9-4522-920D-DA200AB0FD89Q33962557-EDC5BFAC-B0C2-47AA-8905-C1D877ABE9F8Q34086652-FEC118C4-E3C4-45B0-99E9-156540FB84C1Q34132558-D9594D8E-0819-483E-80B6-6733B80E2427Q34421903-1ED436D0-8FF8-4F5B-BEA7-06A8FB851E62Q34574446-DA5AA3A8-C6BF-4379-8415-9C9E9697B337Q35054114-0FCD3E3F-AC09-4BF1-94E9-1B6491AE2252Q35108260-2F3E9181-FFC2-4A2A-ABB5-A72377D5130DQ35137230-29381586-161D-4174-843D-D8E61A51F228Q35222436-3BEBE960-F0BA-4931-A668-8ADDCBA1D583Q35233754-280F7DAC-9D26-4E62-9EC2-72EF01FBF55FQ36378517-B5EFE0DF-5130-4153-B17D-660D304F7F8CQ36507128-53BAFAE7-031C-4724-A188-EA8B0FC62D9AQ36607455-3EC4A7A2-E08D-48EF-80E8-0EF7C212AB72Q36608161-4E572C10-9534-445F-8BC1-58BF737151C6Q36661975-3A07348D-F7FB-4D83-B313-54A5D7F3CBACQ36716040-D58E3696-196C-459A-B56B-DBA875DA6719Q36943683-0F6BAF08-6344-4A9F-B9CF-1BE927B9B86DQ37091345-3FA28BBE-29E1-4395-93B9-82657910B852Q37097161-674BAD92-08BF-45AD-9B2F-32FBC16D8D32Q37257568-7E909289-8C07-4799-A9AD-7B96952100A0Q37257592-5974A5FD-0AC2-4A3C-B080-004FED8EE314Q37412812-2CAFFBEE-85A5-44FA-8D59-1A79E705BEA1Q37417433-137AF6CB-4FC0-4690-97BC-F537E8B369EEQ37478028-A49358F4-3B8B-4C82-AA26-1BAA59BFDA67Q38420503-0D435254-FE7C-4C31-9790-168A9C89B041Q41640666-B729C7AF-FB3A-4823-8B05-26B0ED52CAF2Q50056205-9AEA01D8-61A9-490A-8DD0-169803C5A5CBQ50056959-BC38CF2C-DEA2-424F-AF00-E470EB54DA0BQ58699715-474B627D-B501-42C4-8045-498B88412B79Q58811102-969F8823-4415-42B1-8AC2-EC96BE2B5FA3
P2860
Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Evidence for metabolic and rep ...... ith polycystic ovary syndrome.
@ast
Evidence for metabolic and rep ...... ith polycystic ovary syndrome.
@en
Evidence for metabolic and rep ...... ith polycystic ovary syndrome.
@nl
type
label
Evidence for metabolic and rep ...... ith polycystic ovary syndrome.
@ast
Evidence for metabolic and rep ...... ith polycystic ovary syndrome.
@en
Evidence for metabolic and rep ...... ith polycystic ovary syndrome.
@nl
prefLabel
Evidence for metabolic and rep ...... ith polycystic ovary syndrome.
@ast
Evidence for metabolic and rep ...... ith polycystic ovary syndrome.
@en
Evidence for metabolic and rep ...... ith polycystic ovary syndrome.
@nl
P2093
P2860
P356
P1476
Evidence for metabolic and rep ...... ith polycystic ovary syndrome.
@en
P2093
Andrea Dunaif
Paulina A Essah
Richard S Legro
Teimuraz Apridonidze
P2860
P304
P356
10.1073/PNAS.0602025103
P407
P577
2006-04-21T00:00:00Z